From ESR1 & PIK3CA-guided therapies to novel SERDs, ADCs, and CDK2 inhibitors—treatment sequencing is evolving rapidly. ✅Precision oncology is no longer optional—it’s the standard. OncoDaily OncoAlert LARVOL ascopubs.org/doi/pdf/10.120…

☀️ New data shine light on underrepresentation of #IMGs in academic oncology leadership.   🎙️ Shipra Gandhi of Emory University Winship Cancer Institute of Emory University explains why understanding and addressing the causes can help foster a more inclusive workforce. #ASCO25 bit.ly/3HY73be

“The most dangerous heart disease: strong memory”-Nizar Qabbani (1923-1998)

Drs. Nancy Lin (Nancy Lin, MD) and Rebecca Dent (Rebecca Dent) discuss: 🔹A New Paradigm for Triple-Positive Breast Cancer? 🔹CDK4/6 Inhibitors for HR+/HER2- #BreastCancer 🔹Oral #SERDs for HR+/HER2- Breast Cancer 🔹Treatment of PIK3CA/PTEN/AKT-Mutated Breast Cancer 🔹#ADCs for

Day 1 of #DDHO2025 concluded with the leukemia session, featuring expert panelists from Winship and MD Anderson Cancer Center engaging in Q&A and case study discussions.

Early Career Spotlight Session #4: Dr. Han Yu of Roswell Park (DRCC U24) presents an integrated machine learning-based prognostic model for head and neck cancer, focusing on the Systemic Inflammatory Response Index (SIRI) and its novel association with patient-reported financial

BREAKING: We uncovered a potent immune alliance that could change how we treat solid tumors. Published in Cancer Cell , we show that Th17 cells *must* work with B cells to eliminate tumors—and keep it from coming back. 📄 cell.com/cancer-cell/fu… 🧵1/12👇Let’s walk through it:

Thanks for highlighting our Cancer Cell paper by amazing 1st author Anna Cole Anna Camille! Props to co-1st Hannah Knochelmann, MD PhD as well as to Megan Wyatt, Megen Wittling, & the entire Gregory Lesinski Paulos Lab team Winship Cancer Institute of Emory University. Grateful for help from Jerry Boss & Pawel J. Muranski MD.

Absolutely outstanding breast cancer session at #DDHO2025. Major themes included treatment de-escalation strategies, adjuvant advances making cure even more possible, and of course lifestyle guidance. I am so incredibly excited to join the remarkable team at Winship Cancer Institute of Emory University

The breast cancer session at #DDHO2025 concludes with a patient-based panel discussion and Q&A—bringing together expert perspectives and patient-centered insights to close out a day of impactful dialogue.

Pleased to share the results of our prospective observational decision-impact study in early-stage HR+/HER2− breast cancer (NCT03749421). 🔗sciencedirect.com/science/articl… 🧵👇

Timing of Recurrence After Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer aacrjournals.org/clincancerres/… This analysis of five clinical trials evaluating neoadjuvant chemo-immunotherapy in early-stage triple-negative #BreastCancer (TNBC) highlights that

Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between ⁦Paulos Lab⁩ ⁦Gregory Lesinski⁩! Props to cell therapy gurus ⁦Megen Wittling⁩ ⁦Anna Cole⁩ #MeganWyatt ⁦Winship Cancer Institute of Emory University⁩! v.org/grants/chrysta…

Our new editorial published in JNCI where we discuss how to improve the success rates of phase 3 oncology trials. Led by the brilliant Laure-Anne Teuwen who is soon visiting my unit Queen's University Sinclair Cancer Research Institute for a short-term fellowship. academic.oup.com/jnci/advance-a…

Topo1 ADC sequencing in MBC: Dr. Shipra Gandhi (Winship Cancer Institute of Emory University) presents data showing shorter rwPFS when SG follows T-DXd, hinting at Topo1 cross-resistance. Switching payloads or adding intervening chemo may help. Biomarker-driven approaches are needed. #DAVABreast

Panel@on ctDNA and biomarkers in Breast cancer ⁦DAVA Oncology⁩ #DavaBreast

Can we re-engage anti-HER2/3 immunity in brain-metastatic breast cancer? Dr. Shipra Gandhi from Winship Cancer Institute of Emory University presents a dendritic cell vaccine + PD-1 combo approach in CNS disease (NCT04348747), with a novel Th1/CTL-driven strategy at #DAVABreast #BreastCancer

Starting Now: Novel Immune Checkpoint Approaches Moderated by: Rebecca Shatsky, MD UC San Diego Health #DAVABreast

Starting Now: Cellular Therapies and Vaccine Strategies Moderated by: Dr. Vinay Jain #DAVABreast

I stumbled on this TED Talks. And while the topic is about parenting, I found it was relevant for every relationship. Well worth 14 minutes of our life to listen to this. The critically important concept of "repair". I learnt a lot from this. youtu.be/PHpPtdk9rco?si…